The kicker for me is the progress being made on the Australian Adult double-blind prospective study. Developing the diagnostic tool for kids is fantastic, but IMO the real telehealth opportunity will be in Adults (at least initially, due to the emotions involved when your child is sick and you don't know what to do, so you tend to take them straight to the doctor/hospital).
Get CE-Mark for Adults in Europe and we are off to the commercial races.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides Update on Australian Clinical Study
Ann: ResApp Provides Update on Australian Clinical Study, page-24
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)